Alcohol Use Disorder Treatment Market - Top Companies and Manufacturers

  • Report ID: 3804
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Companies Dominating the Alcohol Use Disorder Treatment Market

    • Alkermes
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Teva Pharmaceutical Industries Ltd.
    •  BioCorRx, Inc.
    • Adial Pharmaceuticals
    • Kinnov Therapeutics
    • ADDEX THERAPEUTICS
    • Indivior PLC 
    • Ethypharm 
    • Omeros Corporation
    • Montisera Ltd./ FINNISH BIOINDUSTRIES FIB

Browse Key Market Insights with Data Illustration:

In the News

  • June 2021- Alkermes plc announced that at the 2021 Research Society on Alcoholism (RSA) Scientific Meeting/International Society for Biomedical Research on Alcoholism (ISBRA) Conference, which was virtually held June 19–23, 2021, new health economics and outcomes research about healthcare resource use (HRU) among veterans with alcohol dependence was presented.
  • August 2024- BioCorRx Inc. declared that it has submitted an extended access program application for BICX104 (implantable naltrexone pellet) to the US Food and Drug Administration (FDA) for the treatment of patients with opioid use disorder (OUD) who satisfy program eligibility requirements.

Author Credits:  Radhika Pawar


  • Report ID: 3804
  • Published Date: Nov 27, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of alcohol use disorder treatment is evaluated at USD 778.89 million.

The alcohol use disorder treatment market size was over USD 742.08 million in 2024 and is projected to reach USD 1.62 billion by 2037, witnessing around 6.2% CAGR during the forecast period i.e., between 2025-2037. Awareness among the population regarding advancement in treatment, supportive government policies, increased healthcare expenditure will drive the market growth.

North America industry is predicted to dominate majority revenue share of 46% by 2037, due to increasing demand for effective treatments in the region.

The major players in the market are Teva Pharmaceutical Industries Ltd., BioCorRx, Inc., Adial Pharmaceuticals, Kinnov Therapeutics, ADDEX THERAPEUTICS, Indivior PLC, Ethypharm, Omeros Corporation, Montisera Ltd./ FINNISH BIOINDUSTRIES FIB, Otsuka Pharmaceutical Co., Ltd., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample